

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.67879223 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 7.67879223 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.30559792 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 7.30559792 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.68782286 |
| 6 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.57716575 |
| 7 | oxidative demethylation (GO:0070989) | 6.33768860 |
| 8 | high-density lipoprotein particle remodeling (GO:0034375) | 5.90824375 |
| 9 | epoxygenase P450 pathway (GO:0019373) | 5.79862090 |
| 10 | ethanol metabolic process (GO:0006067) | 5.79010502 |
| 11 | tryptophan catabolic process (GO:0006569) | 5.74572815 |
| 12 | indole-containing compound catabolic process (GO:0042436) | 5.74572815 |
| 13 | indolalkylamine catabolic process (GO:0046218) | 5.74572815 |
| 14 | phenylpropanoid metabolic process (GO:0009698) | 5.71621293 |
| 15 | urea cycle (GO:0000050) | 5.68299241 |
| 16 | urea metabolic process (GO:0019627) | 5.68299241 |
| 17 | kynurenine metabolic process (GO:0070189) | 5.67416250 |
| 18 | drug catabolic process (GO:0042737) | 5.59752798 |
| 19 | negative regulation of fibrinolysis (GO:0051918) | 5.55875738 |
| 20 | bile acid biosynthetic process (GO:0006699) | 5.51498808 |
| 21 | tryptophan metabolic process (GO:0006568) | 5.46436812 |
| 22 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.31749738 |
| 23 | protein carboxylation (GO:0018214) | 5.31749738 |
| 24 | regulation of fibrinolysis (GO:0051917) | 5.25088600 |
| 25 | cysteine metabolic process (GO:0006534) | 5.24818830 |
| 26 | sulfur amino acid catabolic process (GO:0000098) | 5.23674444 |
| 27 | alpha-linolenic acid metabolic process (GO:0036109) | 5.22511230 |
| 28 | nitrogen cycle metabolic process (GO:0071941) | 5.20846593 |
| 29 | glyoxylate metabolic process (GO:0046487) | 5.16171377 |
| 30 | regulation of cholesterol esterification (GO:0010872) | 5.14694231 |
| 31 | protein activation cascade (GO:0072376) | 5.13674086 |
| 32 | serine family amino acid catabolic process (GO:0009071) | 5.09901991 |
| 33 | exogenous drug catabolic process (GO:0042738) | 5.09736893 |
| 34 | bile acid metabolic process (GO:0008206) | 5.02886843 |
| 35 | reverse cholesterol transport (GO:0043691) | 4.97458498 |
| 36 | S-adenosylmethionine metabolic process (GO:0046500) | 4.96905894 |
| 37 | tyrosine metabolic process (GO:0006570) | 4.96613098 |
| 38 | protein-lipid complex remodeling (GO:0034368) | 4.90436696 |
| 39 | macromolecular complex remodeling (GO:0034367) | 4.90436696 |
| 40 | plasma lipoprotein particle remodeling (GO:0034369) | 4.90436696 |
| 41 | complement activation (GO:0006956) | 4.90142606 |
| 42 | aromatic amino acid family metabolic process (GO:0009072) | 4.85204212 |
| 43 | homocysteine metabolic process (GO:0050667) | 4.84772188 |
| 44 | negative regulation of cholesterol transport (GO:0032375) | 4.83477797 |
| 45 | negative regulation of sterol transport (GO:0032372) | 4.83477797 |
| 46 | flavonoid metabolic process (GO:0009812) | 4.78504325 |
| 47 | regulation of plasminogen activation (GO:0010755) | 4.77593858 |
| 48 | complement activation, classical pathway (GO:0006958) | 4.75744021 |
| 49 | regulation of triglyceride catabolic process (GO:0010896) | 4.66489323 |
| 50 | negative regulation of protein activation cascade (GO:2000258) | 4.65047315 |
| 51 | alpha-amino acid catabolic process (GO:1901606) | 4.64891650 |
| 52 | amino-acid betaine metabolic process (GO:0006577) | 4.64216785 |
| 53 | phospholipid efflux (GO:0033700) | 4.60269141 |
| 54 | cellular glucuronidation (GO:0052695) | 4.60240978 |
| 55 | negative regulation of blood coagulation (GO:0030195) | 4.56781666 |
| 56 | negative regulation of hemostasis (GO:1900047) | 4.56781666 |
| 57 | regulation of humoral immune response (GO:0002920) | 4.52207697 |
| 58 | triglyceride homeostasis (GO:0070328) | 4.49332698 |
| 59 | acylglycerol homeostasis (GO:0055090) | 4.49332698 |
| 60 | lysine metabolic process (GO:0006553) | 4.48740848 |
| 61 | lysine catabolic process (GO:0006554) | 4.48740848 |
| 62 | cellular ketone body metabolic process (GO:0046950) | 4.45381114 |
| 63 | plasma lipoprotein particle clearance (GO:0034381) | 4.44965384 |
| 64 | * drug metabolic process (GO:0017144) | 4.40043682 |
| 65 | regulation of protein activation cascade (GO:2000257) | 4.39196966 |
| 66 | acute-phase response (GO:0006953) | 4.37037672 |
| 67 | complement activation, alternative pathway (GO:0006957) | 4.36588149 |
| 68 | bile acid and bile salt transport (GO:0015721) | 4.27821931 |
| 69 | cholesterol efflux (GO:0033344) | 4.26185777 |
| 70 | low-density lipoprotein particle remodeling (GO:0034374) | 4.25276984 |
| 71 | cellular amino acid catabolic process (GO:0009063) | 4.25218833 |
| 72 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.25042068 |
| 73 | glycine metabolic process (GO:0006544) | 4.24406669 |
| 74 | imidazole-containing compound metabolic process (GO:0052803) | 4.18516448 |
| 75 | benzene-containing compound metabolic process (GO:0042537) | 4.17709455 |
| 76 | opsonization (GO:0008228) | 4.17626497 |
| 77 | hormone catabolic process (GO:0042447) | 4.15970558 |
| 78 | glutamate metabolic process (GO:0006536) | 4.15745954 |
| 79 | negative regulation of wound healing (GO:0061045) | 4.15650436 |
| 80 | negative regulation of coagulation (GO:0050819) | 4.14703823 |
| 81 | negative regulation of lipase activity (GO:0060192) | 4.12020619 |
| 82 | alkaloid metabolic process (GO:0009820) | 4.11005500 |
| 83 | uronic acid metabolic process (GO:0006063) | 4.10660272 |
| 84 | glucuronate metabolic process (GO:0019585) | 4.10660272 |
| 85 | positive regulation of triglyceride lipase activity (GO:0061365) | 4.10410188 |
| 86 | negative regulation of complement activation (GO:0045916) | 4.10208307 |
| 87 | arginine metabolic process (GO:0006525) | 4.09101657 |
| 88 | indolalkylamine metabolic process (GO:0006586) | 4.08692888 |
| 89 | plasma lipoprotein particle assembly (GO:0034377) | 4.04072613 |
| 90 | cellular biogenic amine catabolic process (GO:0042402) | 4.01494603 |
| 91 | amine catabolic process (GO:0009310) | 4.01494603 |
| 92 | serine family amino acid metabolic process (GO:0009069) | 4.00854961 |
| 93 | regulation of complement activation (GO:0030449) | 3.99781347 |
| 94 | aldehyde catabolic process (GO:0046185) | 3.98894442 |
| 95 | regulation of bile acid biosynthetic process (GO:0070857) | 3.98223221 |
| 96 | cytolysis (GO:0019835) | 3.95318503 |
| 97 | coenzyme catabolic process (GO:0009109) | 3.95217844 |
| 98 | cellular modified amino acid catabolic process (GO:0042219) | 3.94619550 |
| 99 | omega-hydroxylase P450 pathway (GO:0097267) | 3.90923457 |
| 100 | serine family amino acid biosynthetic process (GO:0009070) | 3.90101558 |
| 101 | ethanol oxidation (GO:0006069) | 3.89172590 |
| 102 | short-chain fatty acid metabolic process (GO:0046459) | 3.85234248 |
| 103 | ketone body metabolic process (GO:1902224) | 3.84853751 |
| 104 | fibrinolysis (GO:0042730) | 3.83449164 |
| 105 | positive regulation of blood coagulation (GO:0030194) | 3.81008465 |
| 106 | positive regulation of hemostasis (GO:1900048) | 3.81008465 |
| 107 | positive regulation of lipid catabolic process (GO:0050996) | 3.80330471 |
| 108 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.78462296 |
| 109 | cholesterol homeostasis (GO:0042632) | 3.76990416 |
| 110 | carboxylic acid catabolic process (GO:0046395) | 3.74850656 |
| 111 | organic acid catabolic process (GO:0016054) | 3.74850656 |
| 112 | blood coagulation, intrinsic pathway (GO:0007597) | 3.74126915 |
| 113 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.71991459 |
| 114 | steroid catabolic process (GO:0006706) | 3.71095666 |
| 115 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.70646283 |
| 116 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.70646283 |
| 117 | sterol homeostasis (GO:0055092) | 3.70630398 |
| 118 | plasma lipoprotein particle organization (GO:0071827) | 3.68513854 |
| 119 | * xenobiotic metabolic process (GO:0006805) | 3.66173992 |
| 120 | cofactor catabolic process (GO:0051187) | 3.66077777 |
| 121 | protein-lipid complex assembly (GO:0065005) | 3.62832107 |
| 122 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.62300992 |
| 123 | phospholipid homeostasis (GO:0055091) | 3.59647818 |
| 124 | heme transport (GO:0015886) | 3.58395062 |
| 125 | xenobiotic catabolic process (GO:0042178) | 3.56960212 |
| 126 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.55755056 |
| 127 | positive regulation of coagulation (GO:0050820) | 3.49581664 |
| 128 | primary alcohol catabolic process (GO:0034310) | 3.43731072 |
| 129 | arginine catabolic process (GO:0006527) | 3.41315236 |
| 130 | acute inflammatory response (GO:0002526) | 3.41143962 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.39538226 |
| 2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.01057550 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.71092213 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.48944951 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.26381021 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 5.16106313 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.98036965 |
| 8 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 4.00300126 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.87390562 |
| 10 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.10621655 |
| 11 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.7621765 |
| 12 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.89915903 |
| 13 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.88539014 |
| 14 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.72761096 |
| 15 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.59745842 |
| 16 | GATA1_22025678_ChIP-Seq_K562_Human | 1.56419497 |
| 17 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.49750947 |
| 18 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.39445525 |
| 19 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.37302465 |
| 20 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.36729770 |
| 21 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.34455795 |
| 22 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.29394390 |
| 23 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.25913046 |
| 24 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.23550435 |
| 25 | * NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.21946284 |
| 26 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.20925650 |
| 27 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.20708353 |
| 28 | * CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 1.17507779 |
| 29 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.14491994 |
| 30 | * PHF8_20622853_ChIP-Seq_HELA_Human | 1.11368218 |
| 31 | * HNFA_21074721_ChIP-Seq_CACO-2_Human | 1.10940133 |
| 32 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.09588431 |
| 33 | * EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.08428221 |
| 34 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.06290116 |
| 35 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.05408498 |
| 36 | * GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 1.04946309 |
| 37 | * GATA6_21074721_ChIP-Seq_CACO-2_Human | 1.00139885 |
| 38 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.99772043 |
| 39 | * SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.99729019 |
| 40 | * NFYA_21822215_ChIP-Seq_K562_Human | 0.97304315 |
| 41 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.96968039 |
| 42 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.96695736 |
| 43 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.96377658 |
| 44 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.95108451 |
| 45 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.94333977 |
| 46 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.93979510 |
| 47 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.92420957 |
| 48 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.91501270 |
| 49 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.91193543 |
| 50 | * ETV1_20927104_ChIP-Seq_GIST48_Human | 0.90946661 |
| 51 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.90015971 |
| 52 | * CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.89279352 |
| 53 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.88886452 |
| 54 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.88610768 |
| 55 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.88207280 |
| 56 | * SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.87550222 |
| 57 | * CBX2_22325352_ChIP-Seq_293T-Rex_Human | 0.86676361 |
| 58 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.85706186 |
| 59 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.85569007 |
| 60 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.85215649 |
| 61 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.84302391 |
| 62 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.83877862 |
| 63 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.83877862 |
| 64 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.82313717 |
| 65 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.81290769 |
| 66 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.81290769 |
| 67 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.81046719 |
| 68 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.80869701 |
| 69 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.80792980 |
| 70 | * OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.80163810 |
| 71 | * PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 0.79228028 |
| 72 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.78663280 |
| 73 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.78439625 |
| 74 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.78315920 |
| 75 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.78121184 |
| 76 | * NFYB_21822215_ChIP-Seq_K562_Human | 0.77630392 |
| 77 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.77401306 |
| 78 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.77228366 |
| 79 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.77200268 |
| 80 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.76847296 |
| 81 | * RBPJ_21746931_ChIP-Seq_IB4_Human | 0.76631835 |
| 82 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.76284224 |
| 83 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.76284224 |
| 84 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.76034837 |
| 85 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.75968350 |
| 86 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.75601535 |
| 87 | * OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.75198741 |
| 88 | * EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.74438884 |
| 89 | * SOX2_21211035_ChIP-Seq_LN229_Human | 0.73631726 |
| 90 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.73437641 |
| 91 | * EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.73312544 |
| 92 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.71096598 |
| 93 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.70887737 |
| 94 | * RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.70792969 |
| 95 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.70769704 |
| 96 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.70182029 |
| 97 | * STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.69872262 |
| 98 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.69607685 |
| 99 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.68879515 |
| 100 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.68191944 |
| 101 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.68180342 |
| 102 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.67713582 |
| 103 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.66707232 |
| 104 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.65224818 |
| 105 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.65224818 |
| 106 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.64886757 |
| 107 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.64769261 |
| 108 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.63037937 |
| 109 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.59010028 |
| 110 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.58877799 |
| 111 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.57544780 |
| 112 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.57246505 |
| 113 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.56979344 |
| 114 | * CEBPB_22108803_ChIP-Seq_LS180_Human | 0.54570556 |
| 115 | GATA1_19941826_ChIP-Seq_K562_Human | 0.53321760 |
| 116 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.53015824 |
| 117 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.52549033 |
| 118 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.51641137 |
| 119 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.51382398 |
| 120 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.50648884 |
| 121 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.49816984 |
| 122 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.49641929 |
| 123 | AR_20517297_ChIP-Seq_VCAP_Human | 0.49328117 |
| 124 | CBP_21632823_ChIP-Seq_H3396_Human | 0.48882476 |
| 125 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.47828258 |
| 126 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.47236644 |
| 127 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.46834497 |
| 128 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.46159139 |
| 129 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.45337172 |
| 130 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.44850930 |
| 131 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.44743081 |
| 132 | GATA2_19941826_ChIP-Seq_K562_Human | 0.44116458 |
| 133 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.42469118 |
| 134 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.41342234 |
| 135 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.41276466 |
| 136 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.40677400 |
| 137 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.40614485 |
| 138 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.38893681 |
| 139 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.38840322 |
| 140 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.38439998 |
| 141 | * PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.38235933 |
| 142 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.38067739 |
| 143 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.38030720 |
| 144 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.37987856 |
| 145 | LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.37777699 |
| 146 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.37593750 |
| 147 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.36745435 |
| 148 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.35869568 |
| 149 | * CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.35692337 |
| 150 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.35382319 |
| 151 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.34101838 |
| 152 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.34049456 |
| 153 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.34015731 |
| 154 | SOX3_22085726_ChIP-Seq_MUSCLE_Mouse | 0.33107947 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.27895810 |
| 2 | MP0005360_urolithiasis | 7.44687345 |
| 3 | MP0008875_abnormal_xenobiotic_pharmacok | 6.36772513 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 6.21172761 |
| 5 | MP0005365_abnormal_bile_salt | 5.93884995 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 3.93835318 |
| 7 | MP0003252_abnormal_bile_duct | 3.58375323 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.54918725 |
| 9 | MP0009840_abnormal_foam_cell | 3.36827545 |
| 10 | MP0005083_abnormal_biliary_tract | 3.14801505 |
| 11 | MP0003195_calcinosis | 2.95094535 |
| 12 | MP0005332_abnormal_amino_acid | 2.81296397 |
| 13 | MP0001666_abnormal_nutrient_absorption | 2.42662420 |
| 14 | MP0004019_abnormal_vitamin_homeostasis | 2.24427111 |
| 15 | MP0000609_abnormal_liver_physiology | 2.10991846 |
| 16 | MP0003191_abnormal_cellular_cholesterol | 2.09586515 |
| 17 | MP0002118_abnormal_lipid_homeostasis | 2.06818672 |
| 18 | MP0002138_abnormal_hepatobiliary_system | 2.01039807 |
| 19 | MP0005451_abnormal_body_composition | 1.85060957 |
| 20 | MP0005319_abnormal_enzyme/_coenzyme | 1.81066896 |
| 21 | MP0003868_abnormal_feces_composition | 1.77734651 |
| 22 | MP0001764_abnormal_homeostasis | 1.67408994 |
| 23 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.56471521 |
| 24 | MP0009697_abnormal_copulation | 1.55152113 |
| 25 | MP0003186_abnormal_redox_activity | 1.27039704 |
| 26 | MP0009643_abnormal_urine_homeostasis | 1.25198123 |
| 27 | MP0003656_abnormal_erythrocyte_physiolo | 1.23575472 |
| 28 | MP0003011_delayed_dark_adaptation | 1.18494652 |
| 29 | MP0000598_abnormal_liver_morphology | 1.15839274 |
| 30 | MP0009764_decreased_sensitivity_to | 1.15127631 |
| 31 | MP0000604_amyloidosis | 1.13204332 |
| 32 | MP0003705_abnormal_hypodermis_morpholog | 1.10762206 |
| 33 | MP0010368_abnormal_lymphatic_system | 1.03938338 |
| 34 | MP0005670_abnormal_white_adipose | 1.03406249 |
| 35 | MP0009763_increased_sensitivity_to | 1.01457321 |
| 36 | MP0002254_reproductive_system_inflammat | 0.97067106 |
| 37 | MP0005647_abnormal_sex_gland | 0.92606957 |
| 38 | MP0005408_hypopigmentation | 0.88396629 |
| 39 | MP0005636_abnormal_mineral_homeostasis | 0.86771746 |
| 40 | MP0009642_abnormal_blood_homeostasis | 0.86572539 |
| 41 | MP0004782_abnormal_surfactant_physiolog | 0.85671374 |
| 42 | MP0009765_abnormal_xenobiotic_induced | 0.85339664 |
| 43 | MP0008469_abnormal_protein_level | 0.84162866 |
| 44 | MP0002282_abnormal_trachea_morphology | 0.82552270 |
| 45 | MP0005376_homeostasis/metabolism_phenot | 0.79588648 |
| 46 | MP0002078_abnormal_glucose_homeostasis | 0.76649534 |
| 47 | MP0006036_abnormal_mitochondrial_physio | 0.75179464 |
| 48 | MP0003329_amyloid_beta_deposits | 0.74091335 |
| 49 | MP0002971_abnormal_brown_adipose | 0.73314910 |
| 50 | MP0005084_abnormal_gallbladder_morpholo | 0.72962188 |
| 51 | MP0003690_abnormal_glial_cell | 0.72944673 |
| 52 | MP0008872_abnormal_physiological_respon | 0.71685655 |
| 53 | MP0009053_abnormal_anal_canal | 0.70428611 |
| 54 | MP0001661_extended_life_span | 0.69447304 |
| 55 | MP0008874_decreased_physiological_sensi | 0.69133044 |
| 56 | MP0002876_abnormal_thyroid_physiology | 0.68197979 |
| 57 | MP0004130_abnormal_muscle_cell | 0.66540585 |
| 58 | MP0003879_abnormal_hair_cell | 0.65562431 |
| 59 | MP0005334_abnormal_fat_pad | 0.65163124 |
| 60 | MP0005535_abnormal_body_temperature | 0.65017335 |
| 61 | MP0001756_abnormal_urination | 0.64860499 |
| 62 | MP0000639_abnormal_adrenal_gland | 0.63662054 |
| 63 | MP0001915_intracranial_hemorrhage | 0.63261941 |
| 64 | MP0005266_abnormal_metabolism | 0.61724497 |
| 65 | MP0005220_abnormal_exocrine_pancreas | 0.58179638 |
| 66 | MP0005464_abnormal_platelet_physiology | 0.57308381 |
| 67 | MP0003638_abnormal_response/metabolism_ | 0.54601161 |
| 68 | MP0005448_abnormal_energy_balance | 0.54430170 |
| 69 | MP0008873_increased_physiological_sensi | 0.52708203 |
| 70 | MP0002822_catalepsy | 0.51422541 |
| 71 | MP0009785_altered_susceptibility_to | 0.50597675 |
| 72 | MP0005248_abnormal_Harderian_gland | 0.49463917 |
| 73 | MP0002136_abnormal_kidney_physiology | 0.48414292 |
| 74 | MP0005395_other_phenotype | 0.46985018 |
| 75 | MP0003075_altered_response_to | 0.46607585 |
| 76 | MP0002837_dystrophic_cardiac_calcinosis | 0.44709956 |
| 77 | MP0002249_abnormal_larynx_morphology | 0.44584454 |
| 78 | MP0010386_abnormal_urinary_bladder | 0.43157881 |
| 79 | MP0004043_abnormal_pH_regulation | 0.42415973 |
| 80 | MP0003718_maternal_effect | 0.41991255 |
| 81 | MP0003436_decreased_susceptibility_to | 0.41900259 |
| 82 | MP0005167_abnormal_blood-brain_barrier | 0.41368876 |
| 83 | MP0000249_abnormal_blood_vessel | 0.40652514 |
| 84 | MP0003953_abnormal_hormone_level | 0.40074943 |
| 85 | MP0005666_abnormal_adipose_tissue | 0.39621977 |
| 86 | MP0001986_abnormal_taste_sensitivity | 0.39358560 |
| 87 | MP0006035_abnormal_mitochondrial_morpho | 0.38545545 |
| 88 | MP0004883_abnormal_blood_vessel | 0.38486430 |
| 89 | MP0009672_abnormal_birth_weight | 0.38189414 |
| 90 | MP0005551_abnormal_eye_electrophysiolog | 0.37963695 |
| 91 | MP0002090_abnormal_vision | 0.35925634 |
| 92 | MP0002928_abnormal_bile_duct | 0.34989508 |
| 93 | MP0003724_increased_susceptibility_to | 0.34951237 |
| 94 | MP0002332_abnormal_exercise_endurance | 0.34418358 |
| 95 | MP0002168_other_aberrant_phenotype | 0.34300946 |
| 96 | MP0001243_abnormal_dermal_layer | 0.33965461 |
| 97 | MP0009115_abnormal_fat_cell | 0.33032617 |
| 98 | MP0004142_abnormal_muscle_tone | 0.32920132 |
| 99 | MP0000230_abnormal_systemic_arterial | 0.32884236 |
| 100 | MP0005023_abnormal_wound_healing | 0.30547536 |
| 101 | MP0001853_heart_inflammation | 0.28652136 |
| 102 | MP0005164_abnormal_response_to | 0.28184008 |
| 103 | MP0006082_CNS_inflammation | 0.27854457 |
| 104 | MP0005187_abnormal_penis_morphology | 0.27854402 |
| 105 | MP0002132_abnormal_respiratory_system | 0.27128208 |
| 106 | MP0002970_abnormal_white_adipose | 0.26820784 |
| 107 | MP0001881_abnormal_mammary_gland | 0.25616195 |
| 108 | MP0001845_abnormal_inflammatory_respons | 0.25241185 |
| 109 | MP0005166_decreased_susceptibility_to | 0.24850272 |
| 110 | MP0003959_abnormal_lean_body | 0.23465227 |
| 111 | MP0005595_abnormal_vascular_smooth | 0.23219897 |
| 112 | MP0000467_abnormal_esophagus_morphology | 0.22286830 |
| 113 | MP0001984_abnormal_olfaction | 0.21305983 |
| 114 | MP0002135_abnormal_kidney_morphology | 0.21084179 |
| 115 | MP0002269_muscular_atrophy | 0.20572651 |
| 116 | MP0003633_abnormal_nervous_system | 0.19691889 |
| 117 | MP0001440_abnormal_grooming_behavior | 0.19518784 |
| 118 | MP0000566_synostosis | 0.18490946 |
| 119 | MP0001944_abnormal_pancreas_morphology | 0.17861277 |
| 120 | MP0002295_abnormal_pulmonary_circulatio | 0.16563018 |
| 121 | MP0005646_abnormal_pituitary_gland | 0.16434366 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.80134177 |
| 2 | Deep venous thrombosis (HP:0002625) | 7.78914340 |
| 3 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.97704818 |
| 4 | Intrahepatic cholestasis (HP:0001406) | 6.78389537 |
| 5 | Hypobetalipoproteinemia (HP:0003563) | 6.65807271 |
| 6 | Prolonged partial thromboplastin time (HP:0003645) | 6.56538488 |
| 7 | Xanthomatosis (HP:0000991) | 6.33169835 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 6.12029016 |
| 9 | Joint hemorrhage (HP:0005261) | 4.95537067 |
| 10 | Hypolipoproteinemia (HP:0010981) | 4.93200828 |
| 11 | Hyperammonemia (HP:0001987) | 4.75680825 |
| 12 | Abnormality of methionine metabolism (HP:0010901) | 4.70595677 |
| 13 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.56410219 |
| 14 | Epidermoid cyst (HP:0200040) | 4.43378542 |
| 15 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.42984124 |
| 16 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.42952206 |
| 17 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.41967630 |
| 18 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.41210617 |
| 19 | Ketosis (HP:0001946) | 4.38723531 |
| 20 | Hypoalphalipoproteinemia (HP:0003233) | 4.32816832 |
| 21 | Abnormality of the common coagulation pathway (HP:0010990) | 4.27294264 |
| 22 | Hyperglycinemia (HP:0002154) | 4.18960579 |
| 23 | Abnormality of pyrimidine metabolism (HP:0004353) | 4.17823078 |
| 24 | Hyperglycinuria (HP:0003108) | 3.99452203 |
| 25 | Abnormality of glycine metabolism (HP:0010895) | 3.93538138 |
| 26 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.93538138 |
| 27 | Hypercholesterolemia (HP:0003124) | 3.91084762 |
| 28 | Complement deficiency (HP:0004431) | 3.87540360 |
| 29 | Hypoglycemic coma (HP:0001325) | 3.76606241 |
| 30 | Fat malabsorption (HP:0002630) | 3.68152243 |
| 31 | Abnormality of the intrinsic pathway (HP:0010989) | 3.67942768 |
| 32 | Conjugated hyperbilirubinemia (HP:0002908) | 3.51377220 |
| 33 | Hyperbilirubinemia (HP:0002904) | 3.42018170 |
| 34 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.28747011 |
| 35 | Delayed CNS myelination (HP:0002188) | 3.28334163 |
| 36 | Abnormality of nucleobase metabolism (HP:0010932) | 3.25788179 |
| 37 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.24250806 |
| 38 | Abnormality of serum amino acid levels (HP:0003112) | 3.06946396 |
| 39 | Ketoacidosis (HP:0001993) | 3.03495483 |
| 40 | Fair hair (HP:0002286) | 2.99513058 |
| 41 | Hepatocellular carcinoma (HP:0001402) | 2.98135777 |
| 42 | Reduced antithrombin III activity (HP:0001976) | 2.94574125 |
| 43 | Metabolic acidosis (HP:0001942) | 2.86174992 |
| 44 | Myocardial infarction (HP:0001658) | 2.85866105 |
| 45 | Vascular calcification (HP:0004934) | 2.84717612 |
| 46 | Osteomalacia (HP:0002749) | 2.82334099 |
| 47 | Abnormality of complement system (HP:0005339) | 2.80151670 |
| 48 | Abnormality of purine metabolism (HP:0004352) | 2.79770729 |
| 49 | Skin nodule (HP:0200036) | 2.76496586 |
| 50 | Spontaneous abortion (HP:0005268) | 2.73502744 |
| 51 | Steatorrhea (HP:0002570) | 2.72718001 |
| 52 | Glomerulonephritis (HP:0000099) | 2.69213963 |
| 53 | Lethargy (HP:0001254) | 2.68531219 |
| 54 | Spastic diplegia (HP:0001264) | 2.62455197 |
| 55 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.60593483 |
| 56 | Dicarboxylic aciduria (HP:0003215) | 2.60593483 |
| 57 | Gout (HP:0001997) | 2.57092517 |
| 58 | Cerebral edema (HP:0002181) | 2.54571048 |
| 59 | Cardiovascular calcification (HP:0011915) | 2.54043300 |
| 60 | Mitral stenosis (HP:0001718) | 2.50744776 |
| 61 | Neonatal hypoglycemia (HP:0001998) | 2.49574394 |
| 62 | Hypochromic microcytic anemia (HP:0004840) | 2.45676672 |
| 63 | Irritability (HP:0000737) | 2.45173352 |
| 64 | Abnormal gallbladder morphology (HP:0012437) | 2.37837634 |
| 65 | Menorrhagia (HP:0000132) | 2.35887254 |
| 66 | Bile duct proliferation (HP:0001408) | 2.34024649 |
| 67 | Abnormal biliary tract physiology (HP:0012439) | 2.34024649 |
| 68 | Esophageal varix (HP:0002040) | 2.33645600 |
| 69 | Hypoglycemic seizures (HP:0002173) | 2.33366306 |
| 70 | Cholelithiasis (HP:0001081) | 2.30328892 |
| 71 | Acanthocytosis (HP:0001927) | 2.30112887 |
| 72 | Malnutrition (HP:0004395) | 2.28710814 |
| 73 | Neonatal onset (HP:0003623) | 2.26044368 |
| 74 | Amyloidosis (HP:0011034) | 2.22478987 |
| 75 | Purpura (HP:0000979) | 2.21965036 |
| 76 | Arthropathy (HP:0003040) | 2.21946493 |
| 77 | Hyperphosphaturia (HP:0003109) | 2.21842360 |
| 78 | Alkalosis (HP:0001948) | 2.17688776 |
| 79 | Abnormality of urine glucose concentration (HP:0011016) | 2.16688563 |
| 80 | Glycosuria (HP:0003076) | 2.16688563 |
| 81 | Vomiting (HP:0002013) | 2.12794823 |
| 82 | Generalized hypopigmentation of hair (HP:0011358) | 2.11188907 |
| 83 | Enlarged kidneys (HP:0000105) | 2.09416767 |
| 84 | Brushfield spots (HP:0001088) | 2.08788020 |
| 85 | Late onset (HP:0003584) | 2.08414522 |
| 86 | Gingival bleeding (HP:0000225) | 2.06654620 |
| 87 | Generalized aminoaciduria (HP:0002909) | 2.05421829 |
| 88 | Hydroxyprolinuria (HP:0003080) | 2.04612100 |
| 89 | Abnormality of proline metabolism (HP:0010907) | 2.04612100 |
| 90 | Pancreatitis (HP:0001733) | 2.04478277 |
| 91 | Thrombophlebitis (HP:0004418) | 2.04225568 |
| 92 | Poikilocytosis (HP:0004447) | 2.01704862 |
| 93 | Opisthotonus (HP:0002179) | 1.98326627 |
| 94 | Systemic lupus erythematosus (HP:0002725) | 1.97979165 |
| 95 | Abnormal gallbladder physiology (HP:0012438) | 1.95938189 |
| 96 | Cholecystitis (HP:0001082) | 1.95938189 |
| 97 | Nephritis (HP:0000123) | 1.94057730 |
| 98 | Hemorrhage of the eye (HP:0011885) | 1.92129304 |
| 99 | Hypophosphatemic rickets (HP:0004912) | 1.90118332 |
| 100 | Sensorimotor neuropathy (HP:0007141) | 1.88092034 |
| 101 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.87415252 |
| 102 | Abnormal cartilage morphology (HP:0002763) | 1.86792443 |
| 103 | Abnormality of the gallbladder (HP:0005264) | 1.86228635 |
| 104 | Abnormality of iron homeostasis (HP:0011031) | 1.85654810 |
| 105 | Status epilepticus (HP:0002133) | 1.85481463 |
| 106 | Gangrene (HP:0100758) | 1.84167858 |
| 107 | Rickets (HP:0002748) | 1.83619229 |
| 108 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.83056043 |
| 109 | Elevated alkaline phosphatase (HP:0003155) | 1.81445291 |
| 110 | Reticulocytosis (HP:0001923) | 1.78998189 |
| 111 | Pulmonary embolism (HP:0002204) | 1.78962433 |
| 112 | Renal cortical cysts (HP:0000803) | 1.77012490 |
| 113 | Increased serum ferritin (HP:0003281) | 1.76537664 |
| 114 | Abnormality of vitamin metabolism (HP:0100508) | 1.76508420 |
| 115 | Stroke (HP:0001297) | 1.74933161 |
| 116 | Cerebral palsy (HP:0100021) | 1.74743944 |
| 117 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.73146639 |
| 118 | Abnormal urine phosphate concentration (HP:0012599) | 1.68740022 |
| 119 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.67745251 |
| 120 | Atrioventricular block (HP:0001678) | 1.67253848 |
| 121 | Blue irides (HP:0000635) | 1.66034590 |
| 122 | Potter facies (HP:0002009) | 1.62739980 |
| 123 | Facial shape deformation (HP:0011334) | 1.62739980 |
| 124 | Joint swelling (HP:0001386) | 1.61424461 |
| 125 | Retinal atrophy (HP:0001105) | 1.60281107 |
| 126 | Chronic hepatic failure (HP:0100626) | 1.52751935 |
| 127 | Abnormality of the Achilles tendon (HP:0005109) | 1.52048587 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 7.25982224 |
| 2 | SIK1 | 4.61726660 |
| 3 | FGFR4 | 4.34702731 |
| 4 | ERN1 | 3.62082248 |
| 5 | PKN2 | 3.37906893 |
| 6 | INSRR | 2.91360506 |
| 7 | TAOK3 | 2.73987417 |
| 8 | MAP4K2 | 2.57627734 |
| 9 | MAP2K4 | 2.42649748 |
| 10 | FLT3 | 2.32274757 |
| 11 | WNK3 | 2.28834941 |
| 12 | TRIB3 | 2.11883236 |
| 13 | ADRBK2 | 2.11782065 |
| 14 | MST1R | 2.08795664 |
| 15 | DAPK2 | 2.05547276 |
| 16 | PIK3CG | 1.85601804 |
| 17 | MYLK | 1.81360868 |
| 18 | ERBB4 | 1.76422923 |
| 19 | TYK2 | 1.69860016 |
| 20 | LATS1 | 1.55539191 |
| 21 | PTK6 | 1.54122424 |
| 22 | FGFR2 | 1.51255217 |
| 23 | ABL2 | 1.49604485 |
| 24 | TXK | 1.48025977 |
| 25 | KDR | 1.46092377 |
| 26 | NTRK3 | 1.41370891 |
| 27 | ACVR1B | 1.39133750 |
| 28 | BMPR1B | 1.35453033 |
| 29 | MAPK11 | 1.34643070 |
| 30 | WNK4 | 1.32970146 |
| 31 | TIE1 | 1.30616986 |
| 32 | KIT | 1.29323466 |
| 33 | FRK | 1.28073492 |
| 34 | NLK | 1.26838147 |
| 35 | CAMKK2 | 1.21352878 |
| 36 | MAP2K3 | 1.20201865 |
| 37 | PINK1 | 1.17974641 |
| 38 | JAK2 | 1.15727698 |
| 39 | PDK2 | 1.15085760 |
| 40 | PRKG1 | 1.14918686 |
| 41 | PRKACA | 1.13318322 |
| 42 | PRKAA2 | 1.11822656 |
| 43 | TNK2 | 1.07671246 |
| 44 | MAP3K7 | 1.07372855 |
| 45 | GRK6 | 1.07024878 |
| 46 | NEK9 | 1.06964966 |
| 47 | MAPKAPK3 | 1.05720609 |
| 48 | MUSK | 1.03922587 |
| 49 | MAPK4 | 1.03572752 |
| 50 | FER | 1.02989225 |
| 51 | MAP2K2 | 1.00714040 |
| 52 | TBK1 | 0.99716530 |
| 53 | MAP3K14 | 0.99105965 |
| 54 | MAP3K3 | 0.98565424 |
| 55 | TLK1 | 0.96755947 |
| 56 | TGFBR2 | 0.95357484 |
| 57 | PRKCZ | 0.95225628 |
| 58 | CSK | 0.94688104 |
| 59 | JAK1 | 0.93754060 |
| 60 | NUAK1 | 0.91901477 |
| 61 | MAPK12 | 0.89289677 |
| 62 | EPHB1 | 0.86559154 |
| 63 | EPHA4 | 0.86127603 |
| 64 | MAP2K6 | 0.84584678 |
| 65 | MET | 0.83688758 |
| 66 | MAP3K11 | 0.82479328 |
| 67 | PRKCE | 0.78807169 |
| 68 | PRKACG | 0.77328692 |
| 69 | CDK6 | 0.76191187 |
| 70 | CSNK1D | 0.75584292 |
| 71 | MAP3K10 | 0.75412761 |
| 72 | RIPK1 | 0.75330984 |
| 73 | DYRK1B | 0.75240336 |
| 74 | SGK3 | 0.73538045 |
| 75 | STK38L | 0.71650804 |
| 76 | ERBB2 | 0.71364604 |
| 77 | ADRBK1 | 0.68934059 |
| 78 | OBSCN | 0.66542334 |
| 79 | GRK7 | 0.65996326 |
| 80 | SGK1 | 0.65571890 |
| 81 | RET | 0.63374416 |
| 82 | GSK3A | 0.63055908 |
| 83 | PRKACB | 0.62494615 |
| 84 | PTK2 | 0.62315442 |
| 85 | GRK1 | 0.61950104 |
| 86 | OXSR1 | 0.61834855 |
| 87 | MAPK7 | 0.61369193 |
| 88 | MAP3K4 | 0.60493754 |
| 89 | TAOK2 | 0.58823794 |
| 90 | MAP3K12 | 0.58526798 |
| 91 | CAMK1D | 0.58481996 |
| 92 | MAPK13 | 0.57334332 |
| 93 | TRPM7 | 0.56792606 |
| 94 | RPS6KA3 | 0.56763287 |
| 95 | PDPK1 | 0.56250232 |
| 96 | PRKAA1 | 0.55321732 |
| 97 | CSF1R | 0.54950350 |
| 98 | PRKCB | 0.54763779 |
| 99 | SGK2 | 0.54546554 |
| 100 | ZAK | 0.54258293 |
| 101 | CAMK2G | 0.53994482 |
| 102 | PRKCQ | 0.53863126 |
| 103 | EPHA3 | 0.53697801 |
| 104 | FGFR3 | 0.53607423 |
| 105 | STK16 | 0.52043225 |
| 106 | CASK | 0.51802476 |
| 107 | IKBKE | 0.51693241 |
| 108 | CSNK1A1 | 0.51649278 |
| 109 | IGF1R | 0.50565906 |
| 110 | EIF2AK3 | 0.49876451 |
| 111 | DYRK2 | 0.48666088 |
| 112 | CSNK1G1 | 0.48143778 |
| 113 | STK39 | 0.46977501 |
| 114 | MAP3K6 | 0.46271538 |
| 115 | IKBKB | 0.45421874 |
| 116 | MAP3K13 | 0.44339348 |
| 117 | MAP2K1 | 0.44202149 |
| 118 | MAPK15 | 0.43491058 |
| 119 | MAP3K5 | 0.42995406 |
| 120 | PHKG2 | 0.42401497 |
| 121 | PHKG1 | 0.42401497 |
| 122 | BCR | 0.42034905 |
| 123 | STK11 | 0.41882413 |
| 124 | SGK223 | 0.41782089 |
| 125 | SGK494 | 0.41782089 |
| 126 | PRKCG | 0.40843524 |
| 127 | PDK1 | 0.40544986 |
| 128 | LATS2 | 0.36263929 |
| 129 | CSNK1G2 | 0.35935486 |
| 130 | MAP3K2 | 0.35583481 |
| 131 | PIK3CA | 0.35520220 |
| 132 | CAMKK1 | 0.33276182 |
| 133 | PDK3 | 0.32066818 |
| 134 | PDK4 | 0.32066818 |
| 135 | PRKCA | 0.31796063 |
| 136 | EGFR | 0.29034810 |
| 137 | CAMK4 | 0.28915840 |
| 138 | PBK | 0.27837361 |
| 139 | CSNK1G3 | 0.27685738 |
| 140 | MTOR | 0.27049519 |
| 141 | EPHB2 | 0.26604659 |
| 142 | AKT3 | 0.26388909 |
| 143 | CDK4 | 0.26342122 |
| 144 | FGFR1 | 0.25042727 |
| 145 | MAP3K1 | 0.24419333 |
| 146 | ICK | 0.23880863 |
| 147 | PAK3 | 0.22583509 |
| 148 | ITK | 0.21679151 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.03615248 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.72530769 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.71570612 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.46898049 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.07985008 |
| 6 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.74043828 |
| 7 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.73862225 |
| 8 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.69020549 |
| 9 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.50204572 |
| 10 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.44100179 |
| 11 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.40981631 |
| 12 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.38228568 |
| 13 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.38038501 |
| 14 | * Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.37918248 |
| 15 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.37261382 |
| 16 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.35207543 |
| 17 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.33706581 |
| 18 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.26575055 |
| 19 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.04476126 |
| 20 | Retinol metabolism_Homo sapiens_hsa00830 | 1.96788952 |
| 21 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.94409927 |
| 22 | Peroxisome_Homo sapiens_hsa04146 | 1.89385257 |
| 23 | Histidine metabolism_Homo sapiens_hsa00340 | 1.88874077 |
| 24 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.84661256 |
| 25 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.76938236 |
| 26 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.75879541 |
| 27 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.72112542 |
| 28 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.67418504 |
| 29 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.64782856 |
| 30 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.63052231 |
| 31 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.62074342 |
| 32 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.61096460 |
| 33 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.53577143 |
| 34 | Bile secretion_Homo sapiens_hsa04976 | 1.53283470 |
| 35 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.50950013 |
| 36 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.46111550 |
| 37 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.35360164 |
| 38 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.33974034 |
| 39 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.31119157 |
| 40 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.30256035 |
| 41 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.26128720 |
| 42 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.22154956 |
| 43 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.19833056 |
| 44 | ABC transporters_Homo sapiens_hsa02010 | 1.15672947 |
| 45 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.13474130 |
| 46 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.08054814 |
| 47 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.05440242 |
| 48 | Carbon metabolism_Homo sapiens_hsa01200 | 1.04867852 |
| 49 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.03296093 |
| 50 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.00185829 |
| 51 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.90797847 |
| 52 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.90778893 |
| 53 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.83169621 |
| 54 | Sulfur relay system_Homo sapiens_hsa04122 | 0.81868313 |
| 55 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.81699539 |
| 56 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.77033992 |
| 57 | Lysine degradation_Homo sapiens_hsa00310 | 0.76546781 |
| 58 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.76413497 |
| 59 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.67483245 |
| 60 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.66393463 |
| 61 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.65368352 |
| 62 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.61988858 |
| 63 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.53846042 |
| 64 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.49657960 |
| 65 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.47967548 |
| 66 | Metabolic pathways_Homo sapiens_hsa01100 | 0.43313392 |
| 67 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.43051075 |
| 68 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.41385916 |
| 69 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.25836370 |
| 70 | Insulin resistance_Homo sapiens_hsa04931 | 0.20730002 |
| 71 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.19697009 |
| 72 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.19020115 |
| 73 | Galactose metabolism_Homo sapiens_hsa00052 | 0.18424700 |
| 74 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.17289460 |
| 75 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.16308344 |
| 76 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.11668955 |
| 77 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.11050153 |
| 78 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.08487777 |
| 79 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.07840401 |
| 80 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.04404771 |
| 81 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.01421802 |
| 82 | Mineral absorption_Homo sapiens_hsa04978 | 0.00744508 |
| 83 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.2680053 |
| 84 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.2652871 |
| 85 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.2589221 |
| 86 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | -0.2492063 |
| 87 | Pertussis_Homo sapiens_hsa05133 | -0.2428602 |
| 88 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | -0.2368172 |
| 89 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.2362335 |
| 90 | Hepatitis C_Homo sapiens_hsa05160 | -0.2310773 |
| 91 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.2274255 |
| 92 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | -0.2250781 |
| 93 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.2031367 |
| 94 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.2009248 |
| 95 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1970642 |
| 96 | Sphingolipid metabolism_Homo sapiens_hsa00600 | -0.1858629 |
| 97 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1796159 |
| 98 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1734771 |
| 99 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1684855 |
| 100 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1661407 |
| 101 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1647181 |
| 102 | Other glycan degradation_Homo sapiens_hsa00511 | -0.1612726 |
| 103 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1577038 |
| 104 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.1550922 |
| 105 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | -0.1507582 |
| 106 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.1306068 |
| 107 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1229046 |
| 108 | Circadian rhythm_Homo sapiens_hsa04710 | -0.1214856 |
| 109 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | -0.1075034 |
| 110 | Amoebiasis_Homo sapiens_hsa05146 | -0.1037608 |
| 111 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0615007 |
| 112 | Prion diseases_Homo sapiens_hsa05020 | -0.0348918 |

